Apex Biotechnology Dividend
Dividend criteria checks 2/6
Apex Biotechnology is a dividend paying company with a current yield of 3.2%.
Key information
3.2%
Dividend yield
95%
Payout ratio
| Industry average yield | 3.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | NT$1.16 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings
Mar 21
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business
Apr 17Is Apex Biotechnology (TPE:1733) Using Too Much Debt?
Mar 30Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?
Mar 10Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 17A Look At Apex Biotechnology's (TPE:1733) Share Price Returns
Jan 27
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture
Jan 06These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely
Dec 16Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?
Nov 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1733's dividend payments have been volatile in the past 10 years.
Growing Dividend: 1733's dividend payments have fallen over the past 10 years.
Dividend Yield vs Market
| Apex Biotechnology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1733) | 3.2% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Medical Equipment) | 3.2% |
| Analyst forecast in 3 Years (1733) | n/a |
Notable Dividend: 1733's dividend (3.2%) is higher than the bottom 25% of dividend payers in the TW market (1.78%).
High Dividend: 1733's dividend (3.2%) is low compared to the top 25% of dividend payers in the TW market (4.48%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (95%), 1733's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (53.5%), 1733's dividend payments are covered by cash flows.